fbpx

ExpreS2ion Biotechnologies – Presentation of Q1 report 2022

ExpreS2ion Biotechnologies – Presentation of Q1 report 2022 09 JuniJun 2022 13:00 - 13:30 Europe/CopenhagenOnline Event

ExpreS2ion Biotechnologies – Presentation of Q1 report 2022

Watch our live event where CEO of ExpreS2ion Biotechnologies, Bent Frandsen, and the CFO, Keith Alexander presents the Q1 financial results. During the event, it will be possible to ask questions.

Besides the financial results for the quarter, the focus could be on the results of the capital raise carried out in the quarter and updates from the pipeline both on the breast cancer and the late-stage Covid-19 vaccine candidate.

ExpreS2ion Biotechnologies is a Danish pharmaceutical company, which focuses on the development of vaccines. Currently, the company is developing vaccines against Covid-19, breast cancer, and influenza.

Disclaimer: HC Andersen Capital receives payment from ExpreS2ion Biotechnologies for a DigitalIR/Corporate Visibility agreement.

Deltag her

Du vil blive videresendt til en ekstern tilmeldingsside. 

Information

ExpreS2ion Biotechnologies – Presentation of Q1 report 2022 09 JuniJun 2022 13:00 - 13:30 Europe/Copenhagen
ExpreS2ion Biotechnologies – Presentation of Q1 report 2022 Online Event
ExpreS2ion Biotechnologies